VA Disability Rating for Arthritis: How DC 5003 Works (2026)

What DC 5003 Covers

Diagnostic Code 5003 sits in 38 CFR 4.71a, the schedule of ratings for musculoskeletal disabilities. It is the VA's catch-all code for degenerative arthritis, also called osteoarthritis or degenerative joint disease, when the diagnosis is established by X-ray, MRI, or CT imaging. It is one of the most frequently applied musculoskeletal codes because degenerative joint disease is common across the population and especially among veterans whose service involved repetitive impact loading, heavy lifting, parachute landings, prolonged ruck marching, or vehicle crashes.

DC 5003 is distinct from DC 5002, which covers rheumatoid (inflammatory) arthritis and uses a different rating scheme tied to active-disease constitutional symptoms. It is also distinct from DC 5010, which addresses traumatic arthritis but is rated by analogy to DC 5003.

Degenerative Arthritis: The Underlying Disease

Degenerative arthritis is the progressive loss of articular cartilage with secondary changes to the underlying bone, joint capsule, and surrounding soft tissues. Imaging hallmarks include joint space narrowing, subchondral sclerosis, subchondral cysts, and marginal osteophyte formation. The cartilage loss reduces the normal frictionless gliding of joint surfaces and exposes innervated subchondral bone, producing pain on weight-bearing and motion.

The natural history is gradual progression with intermittent flare-ups. Mechanical risk factors include prior joint injury, repetitive loading, obesity, and joint misalignment. Service-related risk factors documented in the literature include lower-extremity impact loading (parachute jumps, foot patrols with heavy loads), repetitive squatting, prolonged kneeling, and blast or vehicle accident exposures.

Clinical features include morning stiffness lasting less than 30 minutes, pain that worsens with activity and improves with rest, crepitus (a grinding or popping sensation) on motion, joint enlargement from bony osteophyte growth, and progressively reduced range of motion. Advanced disease produces instability, locking, or giving way, particularly in the knee.

How the Rating Actually Works

The rating sequence under DC 5003 follows a defined hierarchy.

Step One: Establish X-ray Findings

The diagnosis of degenerative arthritis under DC 5003 must be established by X-ray. MRI or CT findings of osteoarthritic change also satisfy the imaging requirement. A clinical diagnosis without imaging is generally insufficient because the regulation requires objective radiographic confirmation.

Step Two: Apply the Limitation-of-Motion Code

When limitation of motion in the involved joint reaches the compensable threshold under the joint-specific code, DC 5003 directs the rater to use that code rather than 5003. For example, if a veteran has X-ray-confirmed osteoarthritis of the knee with flexion limited to 45 degrees, the rating is 10 percent under DC 5260 (limitation of flexion of the leg). If extension is limited to 10 degrees, the rating is 10 percent under DC 5261. Both can be considered when both planes are limited, subject to the no-pyramiding rule.

Step Three: When Limitation of Motion Is Noncompensable

When the limitation of motion of each involved joint does not meet the compensable threshold under its joint-specific code, DC 5003 provides for a rating based on X-ray-confirmed involvement of multiple joints. The schedule provides:

• 20 percent: X-ray-confirmed involvement of two or more major joints or two or more minor joint groups, with occasional incapacitating exacerbations
• 10 percent: X-ray-confirmed involvement of two or more major joints or two or more minor joint groups, without incapacitating exacerbations

The 10 or 20 percent rating under DC 5003 in this circumstance is a single combined rating across the involved joints rather than a per-joint rating.

What Counts as a Major Joint or Minor Joint Group

38 CFR 4.45 defines the major joints as the shoulder, elbow, wrist, hip, knee, and ankle. Multiple involvements of the interphalangeal, metacarpal, and carpal joints of the upper extremities are considered groups of minor joints, and similar joint groupings apply to the foot. The cervical, dorsal, and lumbar spine segments are considered separately rated.

Painful Motion and 38 CFR 4.59

38 CFR 4.59 instructs that with any form of arthritis, painful motion is an important factor of disability and that joints actually painful, unstable, or malaligned warrant at least the minimum compensable rating for the joint. The Court of Appeals for Veterans Claims has repeatedly reinforced this rule, including in Burton v. Shinseki and Petitti v. McDonald, holding that painful motion alone can warrant the minimum compensable rating even when range of motion is otherwise unimpaired.

The practical implication: a veteran with X-ray-confirmed degenerative arthritis of the knee who has full range of motion but objectively painful motion is entitled to consideration for at least the minimum compensable rating (10 percent) for that joint. The examination must document where in the arc of motion pain begins and the character of the pain (sharp, aching, burning).

DeLuca and Functional Loss

38 CFR 4.40 and 4.45, applied through the DeLuca v. Brown framework, require the rater to consider functional loss beyond what is observable in a single range-of-motion measurement. The DeLuca factors include pain on use, weakness, fatigability, incoordination, and additional limitation of motion during flare-ups or after repetitive use.

Repetitive-Use Testing

The C&P examiner is expected to perform three repetitions of the relevant motion and document whether additional functional loss occurs. When repetitive-use testing demonstrates additional range-of-motion reduction, that reduced range is what the rater uses.

Flare-Up Description

The examiner should attempt to characterize the frequency, duration, severity, and triggers of flare-ups, and to estimate the additional functional loss during a flare-up. When the veteran is not in a flare at the time of the exam, the examiner should provide a best estimate based on the veteran's history.

Functional Limitation Description

The rater is required to consider the impact on activities of daily living and occupational tasks. Statements describing inability to kneel, squat, climb stairs, walk long distances, stand prolonged, lift, grasp, or perform fine motor tasks are functional-loss evidence and should be in the record.

The Bilateral Factor and Pyramiding

When degenerative arthritis affects both sides of the body (for example, bilateral knee or bilateral hip osteoarthritis), the bilateral factor under 38 CFR 4.26 applies. The bilateral factor adds 10 percent to the combined rating of paired extremities before the combined-ratings table is applied, increasing the overall combined rating.

38 CFR 4.14 prohibits pyramiding, the rating of the same manifestation under different diagnostic codes. The rule means that a single joint cannot be rated under both DC 5003 and a limitation-of-motion code at the same time. It also means that pain in the joint cannot be separately rated as a pain disorder when it is already being compensated as a manifestation of the rated arthritis.

Evidence That Supports the Rating

Records that support a thorough rating include the following.

Imaging

X-ray reports describing joint space narrowing, subchondral sclerosis or cysts, and osteophytes. Comparative imaging across time supports a progression argument when applicable. MRI is helpful when cartilage thickness, meniscal pathology, or subchondral bone marrow edema is relevant.

Range-of-Motion Measurements

Goniometer measurements in both flexion and extension (and abduction, adduction, internal and external rotation where applicable) recorded actively and passively, and after three repetitions. The point at which pain begins on motion should be documented for each plane.

Functional-Loss Descriptions

Detailed descriptions from the veteran and from clinicians about flare frequency and duration, additional functional loss during a flare, inability to perform specific occupational tasks, and adaptations the veteran has made.

Treatment History

Prescription history (NSAIDs, intra-articular injections), physical therapy course, brace or assistive device use, and any surgical treatment (arthroscopy, joint replacement) are relevant. Joint replacement triggers a separate rating schedule with a one-year convalescent period.

Lay Statements

Buddy statements from spouses, supervisors, and fellow service members describing observable functional limitation are competent lay evidence for symptoms a layperson can perceive (pain, limp, swelling, inability to perform specific activities).